Significance of next-generation sequencing in the era of targeted therapy for biliary tract cancer: an analysis at a single institution
- DOI
- 10.37349/etat.2026.1002402
- Published
- 2026-09-18
- Container
- Exploration of Targeted Anti-tumor Therapy
- Publisher
- Open Exploration Publishing
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.37349/etat.2026.1002402,
title = {Significance of next-generation sequencing in the era of targeted therapy for biliary tract cancer: an analysis at a single institution},
author = {Kei Nakagawa and Hideaki Sato and Masahiro Iseki and Daisuke Douchi and Shuichi Aoki and Michiaki Unno},
year = {2026},
journal = {Exploration of Targeted Anti-tumor Therapy},
doi = {10.37349/etat.2026.1002402},
url = {https://doi.org/10.37349/etat.2026.1002402}
}RIS
TY - JOUR TI - Significance of next-generation sequencing in the era of targeted therapy for biliary tract cancer: an analysis at a single institution AU - Kei Nakagawa AU - Hideaki Sato AU - Masahiro Iseki AU - Daisuke Douchi AU - Shuichi Aoki AU - Michiaki Unno PY - 2026 JO - Exploration of Targeted Anti-tumor Therapy DO - 10.37349/etat.2026.1002402 UR - https://doi.org/10.37349/etat.2026.1002402 ER -
APA
Nakagawa, K., Sato, H., Iseki, M., Douchi, D., Aoki, S., & Unno, M. (2026). Significance of next-generation sequencing in the era of targeted therapy for biliary tract cancer: an analysis at a single institution. Exploration of Targeted Anti-tumor Therapy. https://doi.org/10.37349/etat.2026.1002402
Source records
- crossref · retrieved 2026-11-10T20:17:17.132Z